In-vitro activity of a new oral streptogramin, RPR 106972, alone and in combination with rifampicin or ciprofloxacin against Legionella spp.

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 5, 1997, Pages 651-653

  Pendland, Susan L ^a   Killian, Aaron D ^a   Woodward, Jennifer G ^a   Rodvold, Keith A ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; ERYTHROMYCIN; RIFAMPICIN; RPR 106972; STREPTOGRAMIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; LEGIONELLA; NONHUMAN;

CIPROFLOXACIN; DRUG THERAPY, COMBINATION; LEGIONELLA; MICROBIAL SENSITIVITY TESTS; RIFAMPIN; VIRGINIAMYCIN;

EID: 0031011270     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.5.651     Document Type: Article

References (8)

1. Dubois, J. & Joly, J. R. (1992). In-vitro activity of RPR 59500, a new synergic antibacterial agent, against Legionella spp. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 77-81.
2. Johnson, D. M., Erwin, M. E., Barrett, M. S., Gooding, B. B. & Jones, R. N. (1992). Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella species. European Journal of Clinical Microbiology & Infectious Diseases 11, 751-5.
3. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Third Edition; Approved Standard M7-A3. NCCLS, Villanova, PA.
4. Eliopoulos, G. M. & Moellering, R. C. (1991). Antimicrobial combinations. In Antibiotics in Laboratory Medicine, 3rd edn (Lorian, V., Ed.), pp. 432-92. Williams & Wilkins, Baltimore, MD.
5. Killian, A. D., Woodward, J. G., Ryu, S. & Pendland, S. L. (1996). Bactericidal activity of RPR 106972 and erythromycin against Legionella pneumophila. In Program and Abstracts of the Third International Conference on the Macrolides, Azalides and Streptogramins, Lisbon, Portugal, 1996. Abstract 1.04, p. 17. Wallace Communications, Atlanta, GA.
6. Pendland, S. L., Martin, S. J., Chen, C., Schreckenberger, P. C. & Danziger, L. H. (1994). Comparison of charcoal and starch based media for susceptibility of 33 clinical isolates of Legionella to erythromycin, ciprofloxacin, clarithromycin, and 14-hydroxy clarithromycin. In Abstracts of the 94th General Meeting of the American Society for Microbiology, Las Vegas, NV, 1994, Abstract C-327, p. 548. American Society for Microbiology, Washington, DC.
7. Hooper, D. C., Wolfson, J. S., Ng, E. Y. & Swartz, M. N. (1987). Mechanisms of action of and resistance to ciprofloxacin. American Journal of Medicine 82, Suppl. 4A, 12-20.
8. Von Rosenstiel, N. & Adam, D. (1994). Quinolone antibacterials. An update of their pharmacology and therapeutic use. Drugs 47, 872-901.